Pfizer and Moderna Raise Prices for COVID-19 Vaccines in EU: Financial Times

By Reuters
Reuters
Reuters
August 1, 2021 Updated: August 1, 2021

Pfizer and Moderna have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported on Sunday.

The new price for the Pfizer shot was €19.50 ($23.15) against €15.50 ($18.40) previously, the newspaper said, citing portions of the contracts seen.

The price of a Moderna vaccine was $25.50 a dose, the contracts show, up from about €19 ($22.5) in the first procurement deal but lower than the previously agreed $28.50 because the order had grown, the report said, citing one official close to the matter.

The European Commission said on Tuesday that the EU is on course to hit a target of fully vaccinating at least 70 percent of the adult population by the end of the summer.

In May, the EU said it expects to have received more than a billion doses of vaccines by the end of September from four drugmakers.

Pfizer and Moderna were not immediately available for comment to Reuters.

By Sabahatjahan Contractor 

Reuters
Reuters